ReposiTrak Beheer
Beheer criteriumcontroles 3/4
De CEO ReposiTrak is Randy Fields, benoemd in Jan1990, heeft een ambtstermijn van 36.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.85M, bestaande uit 60.3% salaris en 39.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 21.56% van de aandelen van het bedrijf, ter waarde $ 31.35M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 16.6 jaar en 13.6 jaar.
Belangrijke informatie
Randy Fields
Algemeen directeur
US$1.9m
Totale compensatie
| Percentage CEO-salaris | 60.33% |
| Dienstverband CEO | 36.7yrs |
| Eigendom CEO | 21.6% |
| Management gemiddelde ambtstermijn | 16.6yrs |
| Gemiddelde ambtstermijn bestuur | 13.6yrs |
Recente managementupdates
Recent updates
TRAK: Expanding Food Traceability Adoption Will Support Future Upside Potential
Analysts kept their fair value estimate for ReposiTrak steady at $16.00, with only minor adjustments to inputs such as the discount rate and future P/E. These changes fine tune their price target view rather than reshape it.ReposiTrak: Walmart And Kroger May Prove The Bears Wrong
Summary ReposiTrak earns a buy rating, targeting $10.2/share by FY 2027, implying 11% upside after a sharp recent pullback. TRAK’s fundamentals remain solid, with profitability and operating leverage improving despite flat Q3 revenue due to FSMA compliance deadline timing shifts. Demand for TRAK’s traceability solutions appears robust, supported by retailer adoption and industry trends beyond regulatory requirements. Risks include slower-than-expected traceability adoption, but TRAK’s scalable SaaS model and regulatory tailwinds underpin an attractive risk-reward profile. Read the full article on Seeking AlphaTRAK: Expanding Traceability And Compliance Adoption Will Support Future Upside Potential
Analysts have adjusted their price target on ReposiTrak to $16.00. The update reflects refreshed assumptions around revenue growth, profit margins, the discount rate and a slightly lower future P/E multiple.TRAK: Expanding Food Traceability Adoption And Compliance Wins Will Drive Upside
Analysts have kept their ReposiTrak price target effectively unchanged at approximately $16.00, reflecting only very small tweaks in inputs such as discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their overall view of the stock. What's in the News A wholesale grocery cooperative in the Southern United States became the first wholesaler to reach full supplier to store traceability using ReposiTrak’s Touchless Traceability solution, achieving FSMA 204 compliance without case-level scanning or changes to distribution center workflows (Key Developments).TRAK: Expanding Traceability Network Adoption Will Support Future Upside
Analysts held ReposiTrak's fair value estimate at $16.00 per share while making only very small tweaks to assumptions such as the discount rate and future P/E, reflecting largely unchanged views on the stock's risk and earnings profile. What's in the News ReposiTrak reported that eighteen fresh fruit and vegetable companies have joined the queue for the ReposiTrak Traceability Network to prepare for FDA Key Data Element sharing across their supply chains, covering a wide range of growers and distributors across the United States (Key Developments).TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have maintained their $16.00 price target on ReposiTrak, linking this steady view to only slight adjustments in discount rate and future P/E assumptions rather than any change in projected growth or profitability. What's in the News ReposiTrak and SPAR Group, Inc.TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have reaffirmed a $16.00 price target for ReposiTrak, citing only minimal tweaks to underlying assumptions such as discount rate, revenue growth, profit margin and future P/E, which together leave their overall valuation view effectively unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability is reported as the first to achieve end to end traceability under FDA FSMA Section 204, with hundreds of thousands of Key Data Element records generated across shipments, and several more corporate customers nearing similar go live milestones (Key Developments).TRAK: Expanding Traceability Network And Share Buybacks Will Support Future Upside
Analysts have modestly reduced their price target on ReposiTrak to reflect a slightly lower future P/E assumption of 36.44x, while keeping key fair value and growth inputs broadly unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability has achieved end to end FSMA 204 traceability, generating hundreds of thousands of FDA Key Data Element records without case level scanning, with three more corporate customers close to similar go live points (Key Developments).TRAK: Traceability Network Adoption Will Support Higher Future Profitability
Analysts have reduced their price target on ReposiTrak from $29 to $16, citing updated assumptions in their models for slower revenue growth, a lower future P/E multiple, and a higher profit margin profile. What's in the News ReposiTrak reported completing a share repurchase program announced on May 9, 2019, buying back a total of 2,220,026 shares, or 11.63% of the company, for US$14.46 million, including 79,927 shares, or 0.44%, repurchased between October 1, 2025 and December 31, 2025 for US$1.1 million (Key Developments).Investors Will Want ReposiTrak's (NYSE:TRAK) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Subdued Growth No Barrier To ReposiTrak, Inc.'s (NYSE:TRAK) Price
ReposiTrak, Inc.'s ( NYSE:TRAK ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...ReposiTrak's (NYSE:TRAK) Performance Is Even Better Than Its Earnings Suggest
ReposiTrak, Inc. ( NYSE:TRAK ) just reported healthy earnings but the stock price didn't move much. Investors are...Earnings Not Telling The Story For ReposiTrak, Inc. (NYSE:TRAK)
With a price-to-earnings (or "P/E") ratio of 62.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...ReposiTrak, Inc. (NYSE:TRAK) Not Lagging Market On Growth Or Pricing
With a price-to-earnings (or "P/E") ratio of 71.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...
Critical Focus On Traceability Solutions Powers Revenue Growth And Profitability Surge
Emphasis on enhancing traceability solutions and strategic revenue focus predicts significant growth, with aims to improve net margins and year-over-year growth.Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
Summary ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, rising operational expenses and heavy FDA dependency pose significant risks. Expansion into adjacent markets and AI-driven operational efficiencies are promising, but traceability revenue remains a small portion of the business. Given the speculative nature and high valuation, I recommend holding off on investing in ReposiTrak at this price. Read the full article on Seeking AlphaReposiTrak, Inc.'s (NYSE:TRAK) P/E Is Still On The Mark Following 28% Share Price Bounce
ReposiTrak, Inc. ( NYSE:TRAK ) shareholders have had their patience rewarded with a 28% share price jump in the last...ReposiTrak (NYSE:TRAK) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Why Investors Shouldn't Be Surprised By ReposiTrak, Inc.'s (NYSE:TRAK) 28% Share Price Surge
Despite an already strong run, ReposiTrak, Inc. ( NYSE:TRAK ) shares have been powering on, with a gain of 28% in the...Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$7m |
| Dec 31 2025 | n/a | n/a | US$7m |
| Sep 30 2025 | n/a | n/a | US$7m |
| Jun 30 2025 | US$2m | US$1m | US$7m |
| Mar 31 2025 | n/a | n/a | US$6m |
| Dec 31 2024 | n/a | n/a | US$6m |
| Sep 30 2024 | n/a | n/a | US$6m |
| Jun 30 2024 | US$2m | US$1m | US$5m |
| Mar 31 2024 | n/a | n/a | US$5m |
| Dec 31 2023 | n/a | n/a | US$5m |
| Sep 30 2023 | n/a | n/a | US$5m |
| Jun 30 2023 | US$2m | US$1m | US$5m |
| Mar 31 2023 | n/a | n/a | US$5m |
| Dec 31 2022 | n/a | n/a | US$4m |
| Sep 30 2022 | n/a | n/a | US$4m |
| Jun 30 2022 | US$2m | US$1m | US$3m |
| Mar 31 2022 | n/a | n/a | US$3m |
| Dec 31 2021 | n/a | n/a | US$3m |
| Sep 30 2021 | n/a | n/a | US$4m |
| Jun 30 2021 | US$2m | US$1m | US$4m |
| Mar 31 2021 | n/a | n/a | US$3m |
| Dec 31 2020 | n/a | n/a | US$2m |
| Sep 30 2020 | n/a | n/a | US$1m |
| Jun 30 2020 | US$2m | US$1m | US$1m |
Compensatie versus markt: De totale vergoeding ($USD 1.85M ) Randy } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 652.98K ).
Compensatie versus inkomsten: De vergoeding van Randy is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Randy Fields (79 yo)
Mr. Randall K. Fields, also known as Randy, co-founded Park City Group, Inc. (Formerly, Fields Software Group) in 1990 and has been its Chairman, Chief Executive Officer and President since June 2001. He s...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 36.7yrs | US$1.85m | 21.56% $ 31.3m | |
| Chief Financial Officer | 7.3yrs | US$460.70k | 0.39% $ 564.2k | |
| General Counsel & Corporate Secretary | 24.5yrs | US$225.00k | 0.34% $ 489.3k | |
| Chief Technology Officer | no data | geen gegevens | geen gegevens | |
| Chief Customer Officer | 8.7yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Sales | no data | geen gegevens | geen gegevens | |
| Vice President of Development | no data | US$147.00k | geen gegevens | |
| Investor Relations Professional | no data | geen gegevens | geen gegevens |
Ervaren management: Het managementteam van TRAK is doorgewinterd en ervaren (gemiddelde ambtstermijn van 16.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 25.3yrs | US$1.85m | 21.56% $ 31.3m | |
| Independent Director | 13.6yrs | US$75.00k | 3.09% $ 4.5m | |
| Director | less than a year | US$8.33k | geen gegevens | |
| Independent Director | 18.9yrs | US$75.00k | 4.34% $ 6.3m | |
| Independent Director | 7.1yrs | US$75.00k | 0.30% $ 437.0k |
Ervaren bestuur: De raad van bestuur van TRAK zijn ervaren en ervaren (gemiddelde ambtstermijn van 13.6 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/13 06:06 |
| Aandelenkoers aan het einde van de dag | 2026/09/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/06/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
ReposiTrak, Inc. wordt gevolgd door 4 analisten. 1 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Thomas Forte | D.A. Davidson & Co. |
| Ananda Baruah | Loop Capital Markets |
| Thomas Forte | Maxim Group |